Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3

Nutrition and Cancer

Volumn 70, Issue 2, 2018, Pages 306-315

  Di, Yunyun ^a   De Silva, Franklyn ^a   Krol, Edward S ^a   Alcorn, Jane ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER SUBFAMILY B; CARBOPLATIN; DOCETAXEL; DOXORUBICIN; ENTEROLACTONE; METFORMIN; SECOISOLARICIRESINOL; 2,3-BIS(3'-HYDROXYBENZYL)BUTYROLACTONE; ANTINEOPLASTIC AGENT; BUTANEDIOL; GAMMA BUTYROLACTONE; LIGNAN;

ARTICLE; CANCER ADJUVANT THERAPY; CELL VIABILITY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; EVIDENCE BASED PRACTICE; HUMAN; HUMAN CELL; IN VITRO STUDY; LINSEED; MDA-MB-231 CELL LINE; METASTATIC BREAST CANCER; OUTCOME ASSESSMENT; SK-BR-3 CELL LINE; ANALOGS AND DERIVATIVES; BREAST TUMOR; CHEMISTRY; DIETARY SUPPLEMENT; DRUG SCREENING; FEMALE; FLAX; IC50; PATHOLOGY; TUMOR CELL LINE;

4-BUTYROLACTONE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; BUTYLENE GLYCOLS; CARBOPLATIN; CELL LINE, TUMOR; DIETARY SUPPLEMENTS; DOCETAXEL; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLAX; HUMANS; INHIBITORY CONCENTRATION 50; LIGNANS; METFORMIN;

EID: 85041130674     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2018.1421677     Document Type: Article

References (55)

1. Siegel RL, Miller KD, and Jemal A, : Cancer statistics, 2015. CA Cancer J Clin 65, 25–29, 2015.
2. Gennari A, Conte P, Rosso R, Orlandini C, and Bruzzi P, : Survival of metastatic breast carcinoma patients over a 20‐year period. Cancer 104, 1742–1750, 2005. doi:10.1002/cncr.21359
3. Twelves C, Jove M, Gombos A, and Awada A, : Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer. Crit Rev Oncol Hematol 100, 74–87, 2016. doi:10.1016/j.critrevonc.2016.01.021
4. Carrick S, Parker S, Thornton CE, Ghersi D, Simes J, et al.: Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Library Syst Rev 15, CD003372, 2009.
5. Baker J, Ajani J, Scotté F, Winther D, Martin M, et al.: Docetaxel-related side effects and their management. Eur J Oncol Nurs 13, 49–59, 2009. doi:10.1016/j.ejon.2008.10.003
6. O'Reilly EA, Gubbins L, Sharma S, Tully R, Guang MH, et al.: The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin 3, 257–275, 2015. doi:10.1016/j.bbacli.2015.03.003
7. Ribeiro JT, Macedo LT, Curigliano G, Fumagalli L, Locatelli M, et al.: Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? Ann Oncol 23, 547–555, 2012. doi:10.1093/annonc/mdr382
8. Smith AR, and Andreansky S, : Antitumor Immunity and Dietary Compounds. Med Sci 2, 1–22, 2013.
9. Buck K, Zaineddin AK, Vrieling A, Heinz J, Linseisen J, et al.: Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. Br J Cancer 105, 1151–1157, 2011. doi:10.1038/bjc.2011.374
10. McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, et al.: Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 122, 229–235, 2012. doi:10.1007/s10549-009-0681-x
11. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, et al.: Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev 16, 2285–2292, 2007. doi:10.1158/1055-9965.EPI-07-0245
12. Zhang W, Wang X, Liu Y, Tian H, Flickinger B, et al.: Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99, 1301–1309, 2008. doi:10.1017/S0007114507871649
13. Begum AN, Nicolle C, Mila I, Lapierre C, Nagano K, et al.: Dietary lignins are precursors of mammalian lignans in rats. J Nutr 134, 120–127, 2004.
14. Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, et al.: Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17, 169–180, 2006. doi:10.1007/s10552-005-0342-2
15. Rowland I, Faughnan M, Hoey L, Wähälä K, Williamson G, et al.: Bioavailability of phyto-oestrogens. Br J Nutr 89, S45–S58, 2003.
16. Mukker JK, Michel D, Muir AD, Krol ES, and Alcorn J, : Permeability and conjugative metabolism of flaxseed lignans by Caco-2 human intestinal cells. J Nat Prod 77, 29–34, 2014. doi:10.1021/np4004905
17. Van De Wetering K, Feddema W, Helms JB, Brouwers JF, and Borst P, : Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo. Gastroenterology 137, 1725–1735, 2009. doi:10.1053/j.gastro.2009.06.052
18. Seibold P, Vrieling A, Johnson TS, Buck K, Behrens S, et al.: Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta‐analysis. Int J Cancer 135, 923–933, 2014. doi:10.1002/ijc.28729
19. Guglielmini P, Rubagotti A, and Boccardo F, : Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Breast Cancer Res Treat 132, 661–668, 2012. doi:10.1007/s10549-011-1881-8
20. Buck K, Vrieling A, Zaineddin AK, Becker S, Husing A, et al.: Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol 29, 3730–3738, 2011. doi:10.1200/JCO.2011.34.6478
21. Olsen A, Christensen J, Knudsen KEB, Johnsen NF, Overvad K, et al.: Prediagnostic plasma enterolactone levels and mortality among women with breast cancer. Breast Cancer Res Treat 128, 883–889, 2011. doi:10.1007/s10549-011-1397-2
22. Setchell KD, Brown NM, Zimmer-Nechemias L, Wolfe B, Jha P, et al.: Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food Funct 5, 491–501, 2014. doi:10.1039/C3FO60402K
23. Sugahara T, Yamauchi S, Nishimoto S, Kondo A, Ohno F, et al.: The structure-activity relationships of flaxseed lignan, secoisolariciresinol. Interdisciplinary Stud Environ Chem—Biol Responses Chem Pollutants 1, 263–268, 2008.
24. Liang C, Li H, Zhou H, Zhang S, Liu Z, et al.: Recombinant Lz-8 from Ganoderma lucidum induces endoplasmic reticulum stress-mediated autophagic cell death in SGC-7901 human gastric cancer cells. Oncol Rep 27, 1079–1089, 2012. doi:10.3892/or.2011.1593
25. Xiao J, Wang Y, Peng J, Guo L, Hu J, et al.: A synthetic compound, 1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one (B63), induces apoptosis and activates endoplasmic reticulum stress in non-small cell lung cancer cells. Int J Cancer 131, 1455–1465, 2012. doi:10.1002/ijc.27406
26. Saggar JK, Chen J, Corey P, and Thompson LU, : Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF‐7 tumor growth through estrogen receptor‐and growth factor‐signaling pathways. Mol Nutr Food Res 54, 415–425, 2015. doi:10.1002/mnfr.200900068
27. Chen J, Power KA, Mann J, Cheng A, and Thompson LU, : Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. Nutr Cancer 58, 162–170, 2007. doi:10.1080/01635580701328271.
28. Billinsky J, Glew RA, Cornish SM, Whiting SJ, Thorpe LU, et al.: No evidence of hypoglycemia or hypotension in older adults during 6 months of flax lignan supplementation in a randomized controlled trial: a safety evaluation. Pharm Biol 51, 778–782, 2013. doi:10.3109/13880209.2013.766220
29. Peuhu E, Rivero-Muller A, Stykki H, Torvaldson E, Holmbom T, et al.: Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis. Oncogene 29, 898–908, 2010. doi:10.1038/onc.2009.386
30. Patterson S, : Metformin may have broad utility in cancer. [https://www.mdanderson.org/publications/oncolog/november-december-2014/beyond-diabetes-metformin-may-have-broad-utility-in-cancer.html] MD Anderson Cancer Center 2014 [cited 2016July].
31. Bodmer M, Meier C, Krähenbühl S, Jick SS, and Meier CR, : Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33, 1304–1308, 2010. doi:10.2337/dc09-1791
32. Col NF, Ochs L, Springmann V, Aragaki AK, and Chlebowski RT, : Metformin and breast cancer risk: a meta-analysis and critical literature review. Breast Cancer Res Treat 135, 639–646, 2012. doi:10.1007/s10549-012-2170-x
33. Lin C, Krol S, and Alcorn J, : The comparison of rat and human intestinal and hepatic glucuronidation of enterolactone derived from flaxseed lignans. Nat Prod J 3, 159–171, 2013.
34. Kotlyarova V, : Pharmacokinetics of Flaxseed Lignans in the Rat (Thesis). 2011.
35. Szerémy P, Pál Á, Méhn D, Tóth B, Fülöp F, et al.: Comparison of 3 assay systems using a common probe substrate, calcein AM, for studying P-gp using a selected set of compounds. J Biomol Screen 16, 112–119, 2011. doi:10.1177/1087057110385230
36. Chou T-C, : Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70, 440–446, 2010. doi:10.1158/0008-5472.CAN-09-1947
37. Mueller H, Kassack MU, and Wiese M, : Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines. J Biomol Screen 9, 506–515, 2004. doi:10.1177/1087057104265386
38. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, et al.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707–712, 1989. doi:10.1126/science.2470152
39. Foulkes WD, Smith IE, and Reis-Filho JS, : Triple-negative breast cancer. N Engl J Med 363, 1938–1948, 2010. doi:10.1056/NEJMra1001389
40. Hicks DG, and Kulkarni S, : HER2+ breast cancer review of biologic relevance and optimal use of diagnostic tools. Am J Clin Pathol 129, 263–273, 2008. doi:10.1309/99AE032R9FM8WND1
41. Chen J, Hui E, Ip T, and Thompson LU, : Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin Cancer Res 10, 7703–7711, 2004. doi:10.1158/1078-0432.CCR-04-1130
42. Chen J, Power KA, Mann J, Cheng A, and Thompson LU, : Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med 232, 1071–1080, 2007.
43. Obermeyer W, Musser S, Betz J, Casey R, Pohland A, and Page S, editors: Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med 208, 6–12, 1995.
44. Eeckhaut E, Struijs K, Possemiers S, Vincken J-P, Keukeleire DD, et al.: Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem. J Agric Food Chem 56, 4806–4812, 2008. doi:10.1021/jf800101s
45. Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, et al.: Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58, 47–52, 2001. doi:10.1016/S0090-4295(01)01014-7
46. Corazzari M, Gagliardi M, Fimia GM, and Piacentini M, : Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol 7, 78, 2017. doi:10.3389/fonc.2017.00078
47. Mukker JK, Singh RSP, Muir AD, Krol ES, and Alcorn J, : Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats. Br J Nutr 113, 749–757, 2015. doi:10.1017/S0007114514004371
48. Kajbaf F, De Broe ME, and Lalau J-D, : Therapeutic concentrations of metformin: a systematic review. Clin Pharmacokinet 55, 439–459, 2016. doi:10.1007/s40262-015-0323-x
49. Wahdan-Alaswad RS, Cochrane DR, Spoelstra NS, Howe EN, Edgerton SM, et al.: Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Horm Cancer 5, 374–389, 2014. doi:10.1007/s12672-014-0188-8
50. Zhuang Y, Chan DK, Haugrud AB, and Miskimins WK, : Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo. PLoS One 9, e108444, 2014. doi:10.1371/journal.pone.0108444
51. Ide T, Ashakumary L, Takahashi Y, Kushiro M, Fukuda N, et al.: Sesamin, a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim Biophys Acta 1534, 1–13, 2001. doi:10.1016/S1388-1981(01)00167-6.
52. Ward WE, Chen J, and Thompson LU, : Exposure to flaxseed or its purified lignan during suckling only or continuously does not alter reproductive indices in male and female offspring. J Toxicol Environ Health A 7, 567–577, 2001. doi:10.1080/15287390152627246
53. Pelicano H, Zhang W, Liu J, Hammoudi N, Dai J, et al.: Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential. Breast Cancer Res 16, 434, 2014. doi:10.1186/s13058-014-0434-6
54. Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, et al.: Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol 1, 778–784, 2015. doi:10.1001/jamaoncol.2015.2378
55. Banerjee A, Ahmed H, Yang P, Czinn SJ, and Blanchard TG, : Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment. Oncotarget 7, 41432–41444, 2016. doi:10.18632/oncotarget.9180